ARCHIVES

Henschke Responds To Questions from The New York Times

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

January 27, 2006

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

In Brief: Angel Bradley To Head NCAB Subcommittee UCLA, USC Join In CCRU Grant Application

September 3, 1982

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

August 11, 1995

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013